FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
Jefferies maintained a Buy rating on Mindray Medical (NYSE: MR) and raised its price target to $36.00 (from $34.00).
Commenting on the company's Q3 report, Jefferies analyst Raj Denhoy said, "MR put up a mixed 3Q with a drastic slowdown in PMLS, a sequential... More


